SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates ROVR, ICVX, HA, IMGN

NEW YORK, Jan. 13, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Rover Group, Inc. (NASDAQ: ROVR)’s sale to affiliates of Blackstone Inc. for $11.00 per share in cash. If you are a Rover shareholder, click here to learn more about your rights and options.

Icosavax, Inc. (NASDAQ: ICVX)’s sale to AstraZeneca for $15.00 per share in cash plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones. If you are an Icosavax shareholder, click here to learn more about your rights and options.

Hawaiian Holdings, Inc. (NASDAQ: HA)’s sale to Alaska Air Group, Inc. for $18.00 per share in cash. If you are a Hawaiian shareholder, click here to learn more about your rights and options.

ImmunoGen, Inc. (NASDAQ: IMGN)’s sale to AbbVie Inc. for $31.26 per share in cash. If you are an ImmunoGen shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com